Literature DB >> 12196821

[Modification of HPV type 16 E6 and E7 genes, and analysis of stability and immunogenicity of the modified proteins].

Huijun Zhi1, Liqun Han, Jiao Ren, Houwen Tian, Weifing Luo, Yu Liang, Li Ruan.   

Abstract

BACKGROUND: To select the mutants of HPV type 16 E6 and E7 genes suitable for construction of vaccine for treatment of cervical cancer.
METHODS: E6 and E7 genes were modified by site-directed mutagenesis. Several recombinant vaccina viruses were constructed by inserting the E6 or E7 mutants into the genome of vaccina virus Tiantan strain and employed to study their antigenicity.
RESULTS: Western blot assay showed that the E6 ?mutant? with substitution of Gly for Leu at amino acid site 50 and E7 mutant with substitution of Gly for Cys-24 and Glu-26 had no effect on their stability and antigenicity, but change of the Cys at position 91 of E7 dramatically reduced its stability and antigencity. Conclusion The results confirmed that the Zinc-finger structure at the E7 C-terminal? plays an important role in the integrity and stability of E7 protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196821

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  2 in total

1.  Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.

Authors:  Li Zhao; Binlei Liu; Jiao Ren; Jing Feng; Zheng Pang; Jian Gao; Hui Zhang; Wenjie Tan; Houwen Tian; Li Ruan
Journal:  Virol J       Date:  2011-06-15       Impact factor: 4.099

2.  C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination.

Authors:  Li-Li Li; He-Rong Wang; Zhi-Yi Zhou; Jing Luo; Xiao-Li Wang; Xiang-Qian Xiao; Yu-Bai Zhou; Yi Zeng
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.